Capability of Utilizing CYP3A5 Polymorphisms to Predict Therapeutic Dosage of Tacrolimus at Early Stage Post-Renal Transplantation

While CYP3A5 polymorphisms are used to predict the initial dosage of tacrolimus therapy, the predictive capability of genetic information for dosing at early stage post-renal transplantation is unknown. We investigated the influence of polymorphisms over time. An initial oral dose of modified-releas...

Descripción completa

Detalles Bibliográficos
Autores principales: Niioka, Takenori, Kagaya, Hideaki, Saito, Mitsuru, Inoue, Takamitsu, Numakura, Kazuyuki, Habuchi, Tomonori, Satoh, Shigeru, Miura, Masatomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307337/
https://www.ncbi.nlm.nih.gov/pubmed/25594874
http://dx.doi.org/10.3390/ijms16011840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307337/
https://www.ncbi.nlm.nih.gov/pubmed/25594874
http://dx.doi.org/10.3390/ijms16011840

Ejemplares similares